Biomed Diagnostics
InTray GC Culture Media, Detect N. Gonorrhoeae from Clinical Specimens, pack/20
- Part Number:
- BIOM-11-080-002
- Lead Time:
- Call for availability: 4-8 weeks
- Minimum Purchase:
- 1 unit
- Shipping:
- FREE SHIPPING on most orders over $50*
- Quantity:
- 20
- Style:
- cell culture
- Country of Origin:
- Made in the USA
Description
InTray® GC Qualitative detection of oral, rectal and genitourethral Neisseria gonorrhoeae colonization (Gonorrhea). N. gonorrhoeae is a common sexually transmitted disease organism broadly disseminated throughout the world. InTray GC is a fully enclosed IVD which enables sample collection, transport, culture and identification in a single device — this simplifies diagnostic procedures, lab costs, and reduces exposure to both the user and the sample. The proprietary modified Thayer-Martin agar is selective for gonococcal bacteria, and results can be interpreted after 24-48 hours incubation.
Temperature sensitive product - Ships Next Day Air only
InTray GC's dynamic built-in components and features are designed for user compatibility and ease of detection.
The following are key highlights that come with this product:
- Single exposure system
- A “ready to start” 5% CO2 environment
- Modified Thayer Martin medium, selective for N. gonorrhoeae
- Direct observation of the culture with anti-fog viewing
- Incubatory and transport capabilities
- Extended 12-month shelf-life
Specifications
Product Principle |
|
Simple Convenience |
|
Accurate Detection |
|
Time to Result | ![]() Incubate 24-48 hours Incubate InTray GC flat to avoid moisture leaking into the CO2 pill chamber. Incubate right side up for 24–48 hours at 37°C (98.6°F) under ambient atmosphere.
|
Storage |
|
Specimen |
|
CPT Codes |
87081 | 87088 | 87070 |
Features and Benefits
Shelf Life and Durability
- Extended 12-month shelf life from date of manufacture
- Designed for specimen collection/inoculation at point-of-care — a fully enclosed IVD for incubation, culture and observation.
- The sealed prepared media device selectively cultures fastidious N. gonorrhoeae species
Key Features
- Fully enclosed IVD with integrated, activatable 5% CO2 system
- Nutritive growth media for selectivity and specificity
Experience a reduction in
- Time-to-result
- Materials waste
- Risk of exposure and contamination
Regulatory
- CE IVD Marked
- FDA Cleared
Articles and Research Papers
Recovery of Neisseria gonorrhoeae from 4 commercially available transport systems
John R. Papp, Diagnostic Microbiology and Infectious Disease Volume 86, Issue 2, October 2016, Pages 144-147 Read
Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present
M Bodie, Can Commun Dis Rep. 2019 Feb 7; 45(2-3): 54–62 Read
Gonorrhea researchers identify novel route to vaccine, new antibiotic
STORY BY: Steve Lundeberg, Oregon State University, 2018 Read
The laboratory diagnosis of Neisseria gonorrhoeae
Lai-King Ng, PhD, Can J Infect Dis Med Microbiol. 2005 Jan-Feb; 16(1): 15–25. Read
Gonococcal antimicrobial susceptibility surveillance in Europe
Results summary 2017, Diagnostic Microbiology and Infectious Disease Volume 86, Issue 2, October 2016, Pages 144-147 Read